Cargando…
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains
Drug repurposing is an attractive strategy for developing new antibacterial molecules. Herein, we evaluated the in vitro antibacterial, antibiofilm, and antivirulence activities of eight FDA-approved “non-antibiotic” drugs, comparatively to tobramycin, against selected Pseudomonas aeruginosa strains...
Autores principales: | Di Bonaventura, Giovanni, Lupetti, Veronica, De Fabritiis, Simone, Piccirilli, Alessandra, Porreca, Annamaria, Di Nicola, Marta, Pompilio, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102761/ https://www.ncbi.nlm.nih.gov/pubmed/35563420 http://dx.doi.org/10.3390/ijms23095029 |
Ejemplares similares
-
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis
por: Di Bonaventura, Giovanni, et al.
Publicado: (2023) -
Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against Pseudomonas aeruginosa From Cystic Fibrosis Patients
por: Di Bonaventura, Giovanni, et al.
Publicado: (2022) -
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis
por: Batoni, Giovanna, et al.
Publicado: (2023) -
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
por: Carullo, Gabriele, et al.
Publicado: (2023) -
In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis
por: Fiscarelli, Ersilia Vita, et al.
Publicado: (2021)